Evidence map›Paper›PMID 34213395›Full record

ArticleHuman vaccines & immunotherapeutics2021

Pneumococcal serotype-specific IgG and opsonophagocytic activity in young Japanese patients with asplenia.

Kenichi Takeshita, Noriko Takeuchi, Yoshiko Takahashi, Chie Fukasawa, Haruka Hishiki, Tadashi Hoshino, Naruhiko Ishiwada, Naoki Shimojo

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Antibiotics (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Kenichi TakeshitaDepartment of Pediatrics, Graduate School of Medicine, Chiba University, Chiba-shi, Japan.ORCID 0000-0002-0869-2342
Noriko TakeuchiDepartment of Infectious Diseases, Medical Mycology Research Center, Chiba University, Chiba-shi, Japan.ORCID 0000-0003-3659-865X
Yoshiko TakahashiDepartment of Pediatrics, Seikeikai Chiba Medical Center, Chiba-shi, Japan.
Chie FukasawaDivision of Infectious Diseases, Chiba Children's Hospital, Chiba-shi, Japan.
Haruka HishikiDepartment of Pediatrics, Graduate School of Medicine, Chiba University, Chiba-shi, Japan.
Tadashi HoshinoDivision of Infectious Diseases, Chiba Children's Hospital, Chiba-shi, Japan.
Naruhiko IshiwadaDepartment of Infectious Diseases, Medical Mycology Research Center, Chiba University, Chiba-shi, Japan.
Naoki ShimojoCenter for Preventive Medical Sciences, Chiba University, Chiba-shi, Japan.
Chiba University · JPChiba Hospital · JPChiba University Hospital · JPTeikyo University Chiba Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with asplenia are at high risks of severe infections caused by encapsulated bacteria, particularly

Indexed as

Antibodies, BacterialPneumococcal InfectionsHumansImmunoglobulin GJapanPneumococcal VaccinesSerogroupVaccines, ConjugateAntibodies, BacterialImmunoglobulin GPneumococcal VaccinesVaccines, Conjugate13-valent pneumococcal conjugate vaccine23-valent pneumococcal polysaccharide vaccineAspleniaopsonophagocytic activityserotype specific IgG level

Identifiers

PMID34213395
PMCPMC8437487
OpenAlexW3175676734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.